Abstract Purpose of Review Chronic inflammation has been recognized as one of the most
important pathophysiological mechanisms' initiation and progression of atherosclerosis …

Cardiovascular diseases (CVDs) are a leading cause of global morbidity and mortality,
significantly driven by chronic inflammation. Interleukin-6 (IL-6) and interleukin-1β (IL-1β) …

In Japan, a super-aged society, deaths from atherosclerotic cardiovascular disease
(ASCVD), especially cardiac diseases including coronary artery disease (CAD) such as …

Background Statin use could benefit patients with non-alcoholic fatty liver disease (NAFLD),
but the evidence is segmented and inconclusive. This multidimensional study …

The term “inflammageing” was introduced in 2000, with the aim of describing the chronic
inflammatory state typical of elderly individuals, which is characterized by a combination of …

Abstract Background Metabolic syndrome (MetS) is accompanied by chronic low-grade
inflammation, and inflammatory markers like high-sensitivity C-reactive protein (hs-CRP) …

Cardiovascular disorders (CVDs) represent a global challenge and are regarded as one of
the leading causes of mortality. The role of inflammation as a risk factor in these disorders …

Statins are widely used for cardiovascular disease prevention but their effects on cognition
remain unclear. Statins reduce cholesterol concentration and have been suggested to …

Background. Persistent inflammation has been recognized as an important comorbid
condition in patients with chronic kidney disease (CKD) and is associated with many …

Objective: Findings among studies evaluating the effect of statin use and OA development in
a 2020 meta-analysis of data from 11 observational studies of statin use and osteoarthritis …